Sort
64,565 grants matching “drug discovery”
AP 1. Biodiversity
$674,974Gary Rosenberg · University Of Utah · U19 · FY2017 · TW
BU-CMD Chemical Library Consortium: Fostering Collaborations between Chemists and Biologists for Translational Discovery
$674,892John A Porco · Boston University (Charles River Campus) · U01 · FY2021 · TR
Enhancing Discovery of HIV Host Genetics using Drug Abuse and other Interactions
$674,890Eric O Johnson · Research Triangle Institute · R01 · FY2016 · DA
Evolution of drug resistance in Candida glabrata
$674,859Gavin J Sherlock · Stanford University · R01 · FY2022 · AI
4/4 The Autism Sequencing Consortium: Autism gene discovery in >20,000 exomes
$674,849Matthew W State · University Of California, San Francisco · U01 · FY2014 · MH
Preclinical Assays of Hippocampal-Prefrontal Cortical Circuit Engagement for Application in Therapeutic Development
$674,785Andrew Porter Maurer · University Of Florida · R01 · FY2022 · MH
Systematic data curation and integration to link models of human disease
$674,775Kara Dolinski · Princeton University · R24 · FY2011 · RR
Development and Excecution of Collaborative High-Throughput Microscopy Assays
$674,697Ty Voss · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Multistage Vectors (MSV) for Ovarian Cancer Therapeutics
$674,633Gabriel Lopez-Berestein · University Of Texas Hlth Sci Ctr Houston · U54 · FY2011 · CA
Mycobacterium tuberculosis antigen diversity
$674,536Joel D. Ernst · New York University School Of Medicine · R01 · FY2011 · AI
Novel Selective Type II kinase Inhibitors to treat Diabetes
$674,446Robert J Devita · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · DK
Novel Selective Type II kinase Inhibitors to treat Diabetes
$674,446Robert J Devita · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DK
Novel Selective Type II kinase Inhibitors to treat Diabetes
$674,446Robert J Devita · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DK
Novel Selective Type II kinase Inhibitors to treat Diabetes
$674,446Robert J Devita · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · DK
Novel Selective Type II kinase Inhibitors to treat Diabetes
$674,446Robert J Devita · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · DK
Intrinsic and synaptic determinants of SNc DA neuron activity and vulnerability
$674,424Dalton James Surmeier · Northwestern University At Chicago · P50 · FY2010 · NS
Advancing On-Slide and Optical Biopsy Tools to Detect High-Risk Oral Premalignancy
$674,252Yu Leo Lei · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · DE
Determining the pathophysiology of pediatric arteriovenous malformation
$674,232Arin K. Greene · Boston Children'S Hospital · R01 · FY2022 · HD
Discovery of Functional Variants in Type 2 Diabetes Genes in Mexican Americans
$674,163Ravindranath Duggirala · Texas Biomedical Research Institute · U01 · FY2013 · DK
New Faculty Recruitment in Stem Cell and Regenerative Cardiovascular Biology
$674,122Allen W Cowley · Medical College Of Wisconsin · P30 · FY2010 · HL
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
$674,121Sergiy Denysenko · Alchem Laboratories Corporation · N02 · FY2019 · CA
Bloomington Drosophila Stock Center at Indiana University
$674,082Kevin R Cook · Trustees Of Indiana University · P40 · FY2015 · OD
Physiological and therapeutic effects of ANGPTL3 variants in mice and humans
$673,864Marina Cuchel · University Of Pennsylvania · R01 · FY2019 · HL
Signal Transduction by Tyrosine Phosphorylation
$673,847Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2012 · CA
Optimization and Modes of Action of NEU-4438, a New Anti-trypanosome Lead Drug
$673,815Kojo Mensa-Wilmot · Kennesaw State University · R01 · FY2024 · AI